Vardenafil hydrochloride (marketed as Levitra) Information
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
Regulatory History of Verdenafil from Drugs@FDA
Includes labeling and approval letters
Information for Healthcare Professionals: Sildenafil (marketed as Viagra and Revatio), Vardenafil (marketed as Levitra), Tadalafil (marketed as Cialis)
FDA Announces Revisions to Labels for Cialis, Levitra and Viagra[ARCHIVED]
FDA news release (10/18/2007)
Questions and Answers about Viagra, Levitra, Cialis, and Revatio: Possible Sudden Hearing Loss